25
Mar 22
Regulatory Training Workshop Series concluded successfully
The Regulatory Training Workshop Series held from February to March 2022 concluded successfully.
14
Jan 22
Webinar – Introduction of the first Advanced Therapy Product GMP Facility in Hong Kong
Dr Daniel Lee of the Chinese University of Hong Kong, introduced the first ATP GMP facility in Hong Kong to our members.
10
Jan 22
GBA Sharing Session 2022
Over 100 members joined the Sharing Session about the Measure of using Hong Kong-registered drugs and medical devices in GBA (“The Measure”).
11
Dec 21
HKAPO Patient Roundtable
The HKAPI co-organized the Patient Roundtable with the Hong Kong Alliance of Patient Organizations (HKAPO) on 11 December afternoon.
26
Nov 21
Patient Support Program Workshop
Over 100 members joined the online Patient Support Program Workshop organized by the Affordability Task Force on 26 November afternoon.
28
May 21
Drug Enlistment Task Force Sharing Session
Over 60 HKAPI members attended our webinar on 28 May where subject matter experts from the Drug Enlistment Task Force provide updates on the current HA drug enlistment system as well as the Macao enlistment system.
24
May 21
Task Force Sharing Series: Enabling Sustainable Access and Affordability
The Affordability Task Force and PPP Task Force co-organized a sharing session for members about Drug Affordability.
14
Jan 21
GBA Training 2020
The Greater Bay Area development has taken centre stage in Hong Kong Policy Address 2020. To facilitate members taking business opportunities in GBA, HKAPI jointly organized a virtual training with the Shenzhen Hospital Manager Association in November and December 2020.
7 Medical Representatives Got Distinction in HKAPI Med Rep Training 2020
The HKAPI Medical Representatives Training Programme has been completed. This year, 63 students are qualified to take the examination. with 7 of them achieving distinction.
18
Dec 19
New Product Submission and Best Practice Workshop
On December 18, 2019, around 70 members from the regulatory affairs and pharmacovigilance department attended the New Product submission and Best Practice Workshop held at HKU.
